Регуляторные исследования и экспертиза лекарственных средств is a peer-reviewed russian-language open-access journal published by Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’) in Russian Federation, operating under an open-access model since 2024. The journal covers Medicine (General).
Authors publish in Регуляторные исследования и экспертиза лекарственных средств without paying any article processing charge (APC) — making it a fully diamond/platinum open-access venue, supported entirely by its publisher or sponsor. Articles are released under the CC BY license (see other journals using this license).
To date, Регуляторные исследования и экспертиза лекарственных средств has published 137 articles. Articles are minted with DOIs through the prefix 10.30895.
Keywords
medicinal products, medications, reference preparations, registration dossier, normative documents, standardization
At a glance
- Country
- Russian Federation
- Primary language
- Russian
- License
- CC BY
- Peer review
- Double anonymous peer review
- OA since
- 2024
- DOI prefix
10.30895
ISSN
- 3034-3062
- electronic
- 3034-3453
Frequently asked questions
Is Регуляторные исследования и экспертиза лекарственных средств peer-reviewed?
Does Регуляторные исследования и экспертиза лекарственных средств charge an article processing charge (APC)?
What subjects does Регуляторные исследования и экспертиза лекарственных средств publish?
What languages does Регуляторные исследования и экспертиза лекарственных средств accept?
What is the ISSN of Регуляторные исследования и экспертиза лекарственных средств?
3034-3062 (print) · 3034-3453 (electronic).